Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional study
The objective of this study is to investigate the correlation between three specific approaches of haemostasis (ROTEM, thrombin generation and coagulation factors/inhibitors) on the same plasma sample from patients with cirrhosis.
DESIGN: A prospective, observational study.
SETTING: Single university hospital.
PARTICIPANTS: Forty patients with cirrhosis.
INTERVENTION: Measurement of the following factors: model for end-stage liver disease (MELD) scores; ROTEM maximum clot firmness (ROTEM-MCF) in EXTEM, INTEM, FIBTEM assays; fibrinogen; factors V and VIII; von Willebrand factor; protein C; protein S; antithrombin; and the thrombin generation test (TGT) enabling the calculation of endogenous thrombin potential without and with thrombomodulin, and the ratio of endogenous thrombin potential with-to-without thrombomodulin (regarded as an index of hypercoagulability).
RESULTS: ROTEM-MCF values were distributed within the normal and hypocoagulation ranges; were correlated to variations in factor V, fibrinogen, protein C and S and antithrombin; and were inversely correlated to MELD scores (Ļā>ā0.5; Pā
Source: European Journal of Anaesthesiology - Category: Anesthesiology Tags: Monitoring Source Type: research
More News: Anesthesia | Anesthesiology | Cirrhosis | Hospitals | Liver | Liver Disease | Study | Urology & Nephrology | von Willebrand Disease